Home/DendroTEK Biosciences/Nathalie Marçal
NM

Nathalie Marçal

Co‑Founder / CSO

DendroTEK Biosciences

Therapeutic Areas

DendroTEK Biosciences Pipeline

DrugIndicationPhase
dPGA (5 mg, 10 mg, 50 mg)Cell‑culture substrate for neuronal and stem‑cell applicationsN/A